BC ECHO on Substance Use – Opioid Use Disorder: Cycle 3, Session 6

Practical considerations for buprenorphine/naloxone induction in primary care settings (precipitated withdrawal and home induction)

Thursday October 8, 12:00-1:00 PM PDT

Presenter: Dr. Tara Andrusiak, MSc., MD CCFP dISAM. Family and Addiction Medicine Physician; Heartwood Treatment Centre for Women; St. Paul’s Hospital (Providence Health Care); Vancouver Detox

At the end of this session, you should be able to:

  1. Effectively and safely conduct a traditional buprenorphine/naloxone induction.
  2. Identify and manage precipitated withdrawal.
  3. Describe micro-induction strategies for buprenorphine/naloxone.
  4. Evaluate which patients would be appropriate for a home induction of buprenorphine/naloxone.
  5. Explain how to do a home induction of buprenorphine/naloxone with a patient, including the use of the Subjective Opiate Withdrawal Scale (SOWS) to assess opioid withdrawal.
  6. Determine which office-based and laboratory tests are clinically useful and appropriate during buprenorphine/naloxone and when to use them